Veriskin
Veriskin - TruScore Cancer Screening Device.
Launch date
Market cap
-
Enterprise valuation
CAD5—8m (Dealroom.co estimates May 2021.)
San Diego California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $2.0m | Grant | |
N/A | N/A | - | |
$1.0m | Seed | ||
$3.9m | Grant | ||
Total Funding | CAD9.4m |